Product Description
The global MIS robotic system market was valued at $8.1 billion in 2024. This is expected to increase over the forecast period at a CAGR of 15.9% to reach $23 billion.
The full report suite on the global market for minimally invasive surgery (MIS) robotic systems includes three segments: capital equipment, disposables and other accessories and services and maintenance revenue. Regional volumes for robotic-assisted MIS procedures are also reported.
This report includes data for 65 countries across 7 different regions. These regions are North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.
An increasing number of emerging competitors are entering the market, which is anticipated to have a notable impact. While Intuitive Surgical has dominated the market in previous years, competitors are beginning to gain modest market share. Companies such as CMR Surgical, Medtronic, SS Innovations, and Distalmotion are making significant progress, particularly in the minimally invasive surgical robotic systems segment with multiple indications. However, the pace of growth is tempered by the lengthy regulatory approval process required for expanding clinical indications.
DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2031, and Historical Data to 2021
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
GLOBAL MINIMALLY INVASIVE SURGERY ROBOTIC SYSTEM MARKET TRENDS
In 2024, the disposables and other accessories market was the largest segment of the overall MIS robotic system market, followed by capital equipment. The services and maintenance segment is the smallest in the overall market and is expected to lose some market share over the forecast period. The disposables and other accessories segment is projected to grow the fastest and gain some market share by the end of the forecast period, owing to the growing number of procedures and installed base. The second-fastest growing segment is the serviced and maintenance revenue. Despite the significant potential for capital equipment market segment in the Asia-Pacific, Europe and other regions, its growth is slower compared to others, as North America approaches market saturation.
GLOBAL MINIMALLY INVASIVE SURGERY ROBOTIC SYSTEM MARKET SHARE INSIGHTS
- Intuitive Surgical dominated the MIS robotic system market in 2024. Since 2000, the company has offered its da Vinci® robotic systems for MIS. Currently, Intuitive is actively marketing its da Vinci® Xi, da Vinci® X and da Vinci® SP In addition to its da Vinci® systems, the company also offers Ion™, a robotic platform for minimally invasive lung biopsies. In 2024, Medtronic announced that it obtained U.S. FDA clearance for its da Vinci® 5, and it reported that for this system alone, there were 362 placed in 2024.
- CMR Surgical, a company based in the U.K., is one of the minor competitors in the MIS robotic system market in 2024. The company reported of performing more than 27,000 procedures using its robot Versius globally, covering Europe, Latin America, Asia, Middle East and Africa. CMR obtained its Conformité Européenne (CE) mark in 2019. Moreover, CMR is expanding its presence; in October 2024, it received its FDA clearance for its Versius with an initial indication for gallbladder removal.
- Medtronic is also another minor competitor that entered the robotic-assisted MIS market in 2021 by launching its MIS robotic-assisted platform, Hugo™ RAS. Currently, Hugo™ RAS is commercially available in certain geographies, but is considered an investigational device in the United States. Medtronic’s solid reputation in the medical devices market will likely help the company to occupy a strong position in the surgical robotics market in the near future.
GLOBAL MINIMALLY INVASIVE SURGERY ROBOTIC SYSTEM MARKET SEGMENTATION SUMMARY
- Capital Equipment Market
- Disposable and Other Accessories Market
- Service and Maintenance Revenue Market
GLOBAL RESEARCH SCOPE
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2024 |
| Forecast Period | 2025-2031 |
| Historical Data | 2021-2023 |
| Quantitative Data | Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Data | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.
|
